Successful treatment of severe primary mitral regurgitation due to rheumatic aetiology using a novel‐designed transcatheter edge‐to‐edge repair system

Abstract

The transcatheter edge‐to‐edge mitral valve repair (TEER) has been recommended as a reliable treatment option for selected patients with severe degenerative and functional mitral regurgitation (MR). Although MR patients with rheumatic etiology were excluded from two significant trials (EVEREST II and COAPT) that established a role for the TEER in degenerative and functional MR. However, it has been reported that the TEER procedure could be safely and effectively performed in carefully selected rheumatic MR patients. Therefore, we share a case report of successfully treating severe rheumatic MR using a novel‐designed TEER system (JensClipTM).